Sorrento Therapeutics Inc

NASDAQ:SRNE   3:59:56 PM EDT
4.25
-0.31 (-6.80%)
4:51:59 PM EDT: $4.25 0.00 (0.00%)
Products

Sorrento Therapeutics Announces FDA Clearance Of Its Ind Application Of Next Generation Ohsv Oncolytic Virus STI-1386

Published: 12/20/2021 14:20 GMT
Sorrento Therapeutics Inc (SRNE) - Sorrento Therapeutics Announces FDA Clearance of Its Ind Application of Next Generation Ohsv Oncolytic Virus Sti-1386 for Patients With Relapsed and Refractory Solid Tumors.